Abstract:OBJECTIVE:To summarize the experience in diagnosis and surgical treatment of hepatic cholangiocarcinoma.METHODS:Clinical features, diagnosis, surgical treatment and prognosis of 52 patients with hepatic cholangiocarcinoma treated at our hospital from 1993 to 2001 were retrospectively reviewed.RESULTS:The patients with hepatic cholangiocarcinoma accounted for 4.1% (52/1261) of the total patients with primary liver carcinoma encountered at this hospital. The ratio of male to female was 1.36:1 in this group. Some patients were complicated by hepatitis B (32.7%), hepatolith (34.6%), liver abscess (13.5%), cirrhosis (53.8%), and serum positivity for alpha-fetaprotein (21.2%). No typical clinical manifestations were present in all patients. The diagnostic rates of ultrasound examination and CT were 80.8% and 94.2%, respectively. The resection rate of hepatic cholangiocarcinoma was 48.1%; and the 1-, 3-, 5-year survival rates were 48.1% (25/52), 30.8% (16/52), and 19.2% (10/52) respectively in this group. In resectable cases, the 1-, 3-, 5-year survival rats were 80.8% (20/25), 48.0% (12/25), 28.0% (7/25) respectively. Seven patients without cirrhosis who had received radical resection and intra-arterial chemotherapy survived for more than 5 years. In unresectable 27 cases, only 5 survived over one year even if selective hepatic arterial embolism and perfusion chemotherapy were employed.CONCLUSIONS:No specific serum marker is found for hepatic cholangiocarcinoma. CT diagnosis is superior to ultrasonography. When a patient has already diagnosed as having hepatolith or liver abscess before operation and occupying lesion is seen intraoperatively, rapid pathological examination should be done for a fair judgement of the nature of the mass and a decision-making of operative protocol. The patient can survive well after curative resection. No matter whether hepatic cholangiocarcinoma is resectable of not, both selective hepatic arterial embolism and perfusion chemotherapy are valuable.

Diagnosis and treatment of nonparasitic hepatic cysts

Surgical strategy for treatment of nonparasitic hepatic cysts

Clinical analysis of 207 cases of hepatic cysts

Analysis of clinical characteristics of non-parasitic hepatic cysts and influencing factors for therapies

Diagnosis and treatment of pancreatic cystic lesions:experience of single center

Diagnosis and treatment of hepatic cysts. Usefulness of intracystic tumor markers (CEA and CA 19.9.)

Congenital Choledochal Cysts in Adults： Twenty-Five-year Experience

[Diagnosis and Treatment of Cystic Renal Cell Carcinoma: a Report of 14 Cases].

Surgical Management of Non-Parasitic Hepatic Cyst with Biliary Communication: a Case Report

[Diagnosis and Treatment of Congenital Biliary Duct Cyst: Twenty-Year Experience].

Principles of diagnosis and treatment for hepatolithiasis

Rare type of hepatic benign tumor and tumor-like lesions

Hepatic Cystic Lesions Mimicking Liver Abscess on Imaging: A Report of Two Cases

Diagnosis and treatment of pancrean cystic neoplasms:hot and difficult problems

[The thinking of several issues in the diagnosis and treatment of pancreatic cystic tumor]

Clinicopathological features,diagnosis and treatment of hepatolithiasis complicated with cholangiocarcinoma

MINIMALLY INVASIVE METHODS FOR TREATING LIVER CYSTS

Surgical diagnosis and treatment for pancreatic cystic lesions:161 resected cases summary

Diagnosis and Treatment of Hepatic Cholangiocarcinoma: Report of 52 Cases.

A Retrospective Analysis of the Surgical Therapy of Cystic Lesions in the Liver

Intrahepatic Biliary Cystadenoma Presenting with Pleural Effusion